Eugia US LLC Recalls Acyclovir Sodium Injection 500 mg per 10 mL


Medical Recalls

Kroger Aspirin 81 mg Delayed-Release enteric coated tablets 300 count bottle
Teva IDArubicin Hydrochloride Injection
Levetiracetam Injection USP
acyclovir sodium injection 500 mg per 10 ml

Acyclovir Sodium Injection 500 mg per 10 mL


Eugia US LLC (formerly AuroMedics Pharma LLC) has initiated a voluntary recall of lot number AC22006 of AuroMedics Acyclovir Sodium Injection 500 mg per 10 mL (50 mg/mL), 10 mL single dose vial to the consumer level from the U.S. market due to a product complaint for the presence of a dark red, brown and black particulate inside the vial.

AuroMedics Acyclovir Sodium Injection 500 mg per 10 mL (50 mg/mL), contains acyclovir, a synthetic nucleoside analog, active against herpes viruses. Acyclovir Sodium Injection is indicated for the treatment of initial and recurrent mucosal and cutaneous herpes simplex (HSV- 1 and HSV-2) in immunocompromised patients and initial clinical episodes of herpes genitalis in immuno-competent patients. It is packaged in a glass vial labeled with NDC 55150-154-10. The lot being recalled is AC22006 with an expiration date of 08/2023. Eugia US LLC shipped the entire lot to wholesalers nationwide from June 8, 2022, through June 13, 2022.

Eugia US LLC is notifying its direct consignees by recall letters and is arranging for return/ replacement of all recalled product. 

Source: FDA

You Are Leaving Us

This link is being provided as a convenience and for informational purposes only it is not an endorsement or an approval of any of the products, services or opinions of the corporation or organization or individual.

Recallinsider.com bears no responsibility for the accuracy, legality or content of the external site or for that of subsequent links.

Consumer Contact: –

Wholesale customers and health professionals that have the product lot which is being recalled should immediately place the recalled lot on hold and contact Qualanex at 1-888-280-2046 or email recall@qualanex.com (live calls received 7:00 am to 4:00 pm M-F CST).

Patients / consumers that have the product lot which is being recalled should contact Qualanex (telephone 1-888-280-2046 or email recall@qualanex.com), or their physician as appropriate.

Consumers with medical questions regarding this recall or to report an adverse event can contact the Drug Safety Department from 8:00 am to 5:00 pm M-F EST at:

  • 1-866-850-2876 Option 2
  • pvg@aurobindousa.com

Consumers should contact their physician or healthcare provider if they have experienced any problems that may be related to taking or using this drug product.

General questions regarding the return of this product should be directed to Qualanex at 1-888-280-2046 or email recall@qualanex.com (live calls received 7:00 am to 4:00 pm M-F CST).

You Are Leaving Us

This link is being provided as a convenience and for informational purposes only it is not an endorsement or an approval of any of the products, services or opinions of the corporation or organization or individual.

Recallinsider.com bears no responsibility for the accuracy, legality or content of the external site or for that of subsequent links.

You Are Leaving Us

This link is being provided as a convenience and for informational purposes only it is not an endorsement or an approval of any of the products, services or opinions of the corporation or organization or individual.

Recallinsider.com bears no responsibility for the accuracy, legality or content of the external site or for that of subsequent links.

You Are Leaving Us

This link is being provided as a convenience and for informational purposes only it is not an endorsement or an approval of any of the products, services or opinions of the corporation or organization or individual.

Recallinsider.com bears no responsibility for the accuracy, legality or content of the external site or for that of subsequent links.

The administration of an intravenous product containing particulates has the potential to result in inflammation, allergic reactions, or circulatory system complications which could be life-threatening. To date, Eugia US LLC has not received reports of any adverse events or identifiable safety concerns attributed to the product consumed for this lot.


Report a Problem With This Product

Adverse reactions or quality problems experienced with the use of this product may be reported to the FDA’s MedWatch Adverse Event Reporting program either online, by regular mail or by fax.

You Are Leaving Us

This link is being provided as a convenience and for informational purposes only it is not an endorsement or an approval of any of the products, services or opinions of the corporation or organization or individual.

Recallinsider.com bears no responsibility for the accuracy, legality or content of the external site or for that of subsequent links.

You Are Leaving Us

This link is being provided as a convenience and for informational purposes only it is not an endorsement or an approval of any of the products, services or opinions of the corporation or organization or individual.

Recallinsider.com bears no responsibility for the accuracy, legality or content of the external site or for that of subsequent links.

You Are Leaving Us

This link is being provided as a convenience and for informational purposes only it is not an endorsement or an approval of any of the products, services or opinions of the corporation or organization or individual.

Recallinsider.com bears no responsibility for the accuracy, legality or content of the external site or for that of subsequent links.

Related Posts

adam’s polishes hand sanitizers
Adam’s Polishes, LLC Recalls Hand Sanitizer
FDA testing has found this lot to contain undeclared methanol.
viatris logo
Mylan Institutional LLC, a Viatris Company Recalls One Lot of Octreotide Acetate Injection
Recalled due to a product complaint of the presence of glass particles in a syringe.
clorox pine sol products
Clorox® Recalls Various Pine-Sol Products
The recalled products may contain bacteria, including Pseudomonas aeruginosa
quinapril and hydrochlorothiazide tablets
Aurobindo Pharma USA, Inc. Recalls Two Lots of Quinapril and Hydrochlorothiazide Tablets
Recalled due to presence of Nitrosamine Drug Substance Related Impurity.

Latest Posts

weis quality premium sea salt and caramel ripple ice cream
Weis Markets Recalls Weis Quality Premium Sea Salt and Caramel Ripple Ice Cream
green sprouts sippy cups
Green Sprouts Recalls Toddler’s Stainless Steel Bottles and Cups
indigo papa bear and mama bear mugs
Indigo Books & Music Recalls Indigo Branded Bear Mugs
bentex jersey leggings set
Bentex Recalls Children’s Clothing Sets
Product Image Not Available
Phil’s Power Pancake Recalls 5oz. Packages of Individually Wrapped Power Pancakes

Leave a Comment

Your email address will not be published. Required fields are marked *

You cannot copy content of this page